Validation of Ultra-high Sensitive SIMOA Assays for the Quantitation of NF-L and GFAP

In this poster, we validate ultra-high sensitive SIMOA assays for the successful quantitation of neurofilament light chain (NF-L) and glial fibrillary acidic protein (GFAP).

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Phone

This field is for validation purposes and should be left unchanged.

Validation of Ultra-high Sensitive SIMOA Assays for the Quantitation of NF-L and GFAP

Resources to Consider

Method Validation of Quantitation IL-17A in Human Serum using the...

An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous...

Achieving sensitive and specific oligonucleotide quantification by...

Development and Validation of an Ultra Sensitive LC-MS/MS Method for...

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...

Neurofilament Light Chain: Method Validation of Quantitation Using...

Validating The Simoa Technology

Quantitative Assessment of mRNA Drug Biological Activity by...

Immunoassays for Drug Discovery

Utilizing Ligand Binding Assays (LBA) and Critical Reagents for Drug...

Ligand Binding Assays (LBAs) and Critical Reagents

Sequencing Assays for Biomarker Discovery and Pharmacodynamics in...